logo

Roche Holding Ag (RHHBY)



Trade RHHBY now with
  Date
  Headline
5/21/2018 2:03:48 AM Genentech Announces Full Results From Phase III HAVEN 3 Study Evaluating HEMLIBRA
5/15/2018 3:10:17 AM Roche: FDA Approves Subcutaneous Formulation Of Actemra For Use In Active PJIA
5/14/2018 1:05:50 AM Genentech To Present New Phase III Data For HEMLIBRA In People With Hemophilia A At WFH 2018
5/14/2018 1:02:36 AM Roche Announces FDA Approval Of An Additional Claim For Cobas Zika Test For Use On Cobas 6800/8800 Systems
5/10/2018 1:04:11 AM Genentech: Phase III IMblaze370 Study Of TECENTRIQ And COTELLIC Did Not Meet Primary Endpoint Of OS Vs Regorafenib
5/8/2018 1:16:07 AM Genentech To Present New Data From Oncology Portfolio At 2018 ASCO Annual Meeting
5/7/2018 1:05:40 AM FDA Grants Priority Review To Genentech’s Cancer Immunotherapy TECENTRIQ (Atezolizumab)
4/26/2018 1:01:26 AM Roche Q1 Group Sales Up 6% To CHF 13.6 Bln
4/23/2018 1:02:00 AM Genentech Presents New OCREVUS (ocrelizumab) Data At The 70th American Academy Of Neurology Annual Meeting
4/17/2018 1:01:42 AM FDA Grants Breakthrough Therapy Designation For Genentech’s HEMLIBRA In Hemophilia A Without Inhibitors